Target intelligence / Profile preview

Hematopoiesis-supporting stroma

Molecular classification
Other (cellular microenvironment), Not a single molecule or receptor
01

Overview

The term "hematopoiesis-supporting stroma" refers to the complex network of nonhematopoietic cells within the bone marrow that provides structural and functional support for blood cell formation. This stroma is not a single molecular target but rather an ensemble that includes mesenchymal stromal/stem cells, endothelial cells, fibroblasts, adipocytes, osteoblasts/osteolineage cells, pericytes, macrophages, and neural elements[2][3][4][5]. These diverse cell types form specialized "niches" that regulate the self-renewal and differentiation of hematopoietic stem and progenitor cells through direct contact as well as secretion of soluble factors such as CXCL12/SDF1α, stem cell factor (SCF), intercellular adhesion molecules like ICAM1, transforming growth factor-beta (TGFβ), among others[2][3][5]. The stroma's primary function is to maintain normal blood production by providing both physical scaffolding and biochemical signals necessary for HSC survival. Disruption or dysfunction in this supportive environment can contribute to diseases such as bone marrow failure syndromes or malignancies like leukemia by altering normal regulatory cues[3]. The concept is operationally defined by its ability to support hematopoiesis in vitro or in vivo rather than being a discrete molecular entity[4]. Because "hematopoiesis-supporting stroma" describes a multicellular tissue context rather than an individual protein/receptor/enzyme/transporter typically considered drug targets in pharmacology or molecular medicine—and because it lacks canonical abbreviation—this entry should be flagged as incorrect if used where a specific therapeutic target is required.

Other names
Bone marrow stromal compartmentHematopoietic stromaBone marrow microenvironmentStromal cells of bone marrow
02

Biological functions

Support of hematopoiesisRegulation of hematopoietic stem cell (HSC) self-renewal and differentiationFormation of the hematopoietic niche/microenvironmentSecretion of growth factors and cytokines for HSC maintenance
03

Disease associations

Cancer (e.g., leukemia via altered microenvironment)Bone marrow failure syndromes (e.g., aplastic anemia)Immune dysregulation/autoimmune disease
04

Biomarkers

CXCL12-abundant reticular cells (CAR cells) as niche markers[5]

Beyond the preview

Go deeper on Hematopoiesis-supporting stroma.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Hematopoiesis-supporting stroma.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call